SEC Form 4 · accession 0001019056-18-000778
Aptevo Therapeutics Inc. · APVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Abdun-Nabi
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 4, 2018 · 6:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001671584
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.49 | Jun 1, 2018 | A | 25,000 | A | — | May 31, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning on May 31, 2019.